ACADIAN ASSET MANAGEMENT LLC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 916542 Boston, MA

Position in ARCT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$883,350

-$1,282,110 QoQ

Shares Held

131,451

-53.1% QoQ

Ownership

0.462%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 133 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. ARCT ranks #69 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$883,350	131,451	-53.1%	Shares	Defined	2026-08-13
2026-03-31	$2,165,460	280,500	-34.4%	Shares	Defined	2026-05-13
2025-12-31	$2,622,990	427,894	+81.0%	Shares	Defined	2026-02-10
2025-09-30	$4,355,838	236,345	+71.4%	Shares	Defined	2025-11-13
2025-06-30	$1,794,105	137,902	+107.9%	Shares	Defined	2025-08-07
2025-03-31	$702,561	66,342	+552.3%	Shares	Defined	2025-05-21
2024-09-30	$236,068	10,171	-47.0%	Shares	Defined	2024-11-12
2023-06-30	$550,111	19,181	+19081.0%	Shares	Defined	2023-08-07
2023-03-31	$2	100	-99.9%	Shares	Defined	2023-05-11
2022-09-30	$1,112,196	75,047	+34.9%	Shares	Defined	2022-11-14
2020-06-30	$2,600,707	55,642	+78.3%	Shares	Defined	2020-08-12
2020-03-31	$424,089	31,206	—	Shares	Defined	2020-05-11
No filing history on record for this holder in this stock.